Folisurge 150 Injection contains recombinant follicle stimulating hormone (FSH) at a strength of 150 IU, a vital gonadotropin used primarily in the treatment of infertility. This hormone plays a crucial role in stimulating the growth and maturation of ovarian follicles in women undergoing assisted reproductive technologies such as in vitro fertilization (IVF) or controlled ovarian hyperstimulation. By promoting follicular development, Folisurge 150 helps enhance the chances of successful ovulation and conception. In men, it may be used to stimulate spermatogenesis in cases of hypogonadotropic hypogonadism. The recombinant nature of the FSH in Folisurge ensures high purity and consistent biological activity, minimizing the risk of immunogenic reactions compared to urinary-derived products. Administration is typically via subcutaneous or intramuscular injection, with dosage and duration tailored according to individual patient response and treatment protocols. Patients should be monitored regularly through ultrasound and hormone assays to assess follicular growth and avoid complications such as ovarian hyperstimulation syndrome (OHSS). Folisurge 150 Injection should be used under strict medical supervision, and patients should inform their healthcare provider of any allergies, medical conditions, or concurrent medications to ensure safe and effective treatment outcomes.